Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity

Open access

Abstract

Oridonin (Ori) is the major active ingredient of the traditional Chinese medicinal herb Rabdosia rubescens and has anti-inflammatory activity, but the target of Ori remains unknown. NLRP3 is a central component of NLRP3 inflammasome and has been involved in a wide variety of chronic inflammation-driven human diseases. Here, we show that Ori is a specific and covalent inhibitor for NLRP3 inflammasome. Ori forms a covalent bond with the cysteine 279 of NLRP3 in NACHT domain to block the interaction between NLRP3 and NEK7, thereby inhibiting NLRP3 inflammasome assembly and activation. Importantly, Ori has both preventive or therapeutic effects on mouse models of peritonitis, gouty arthritis and type 2 diabetes, via inhibition of NLRP3 activation. Our results thus identify NLRP3 as the direct target of Ori for mediating Ori’s anti-inflammatory activity. Ori could serve as a lead for developing new therapeutics against NLRP3-driven diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-04947-6

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Ori blocks NLRP3 activation. a Ori structure. b BMDMs were primed with LPS and then stimulated with nigericin for 0.5 h with or without Ori. Western blot analysis of cleaved IL-1β, activated caspase-1 (P20) in culture supernatants (SN) and pro-IL-1β, pro-caspase-1 in lysates (Input) of BMDMs. c, d IL-1β (c) or TNF-α (d) production (as measured by ELISA) in SN from BMDMs primed with LPS and stimulated with nigericin for 0.5 h with or without Ori. e, f Western blot analysis (e) of cleaved IL-1β and activated caspase-1 or ELISA (f) of IL-1β in SN from BMDMs primed with LPS and stimulated with MSU, nigericin or ATP in the presence or absence of Ori (2 μM). g–i Western blot analysis of cleaved IL-1β and activated caspase-1 (g) or ELISA of IL-1β (h) or TNF−α (i) production in SN from PBMCs pretreated with Ori for 0.5 h and stimulated with LPS for 16 h. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (c, d, f, h, i) or are representative of three independent experiments (b, e, g). Statistical differences were calculated by unpaired Student’s t-test: ***P < 0.001
Fig. 1 Ori blocks NLRP3 activation. a Ori structure. b BMDMs were primed with LPS and then stimulated with nigericin for 0.5 h with or without Ori. Western blot analysis of cleaved IL-1β, activated caspase-1 (P20) in culture supernatants (SN) and pro-IL-1β, pro-caspase-1 in lysates (Input) of BMDMs. c, d IL-1β (c) or TNF-α (d) production (as measured by ELISA) in SN from BMDMs primed with LPS and stimulated with nigericin for 0.5 h with or without Ori. e, f Western blot analysis (e) of cleaved IL-1β and activated caspase-1 or ELISA (f) of IL-1β in SN from BMDMs primed with LPS and stimulated with MSU, nigericin or ATP in the presence or absence of Ori (2 μM). g–i Western blot analysis of cleaved IL-1β and activated caspase-1 (g) or ELISA of IL-1β (h) or TNF−α (i) production in SN from PBMCs pretreated with Ori for 0.5 h and stimulated with LPS for 16 h. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (c, d, f, h, i) or are representative of three independent experiments (b, e, g). Statistical differences were calculated by unpaired Student’s t-test: ***P < 0.001CC BY · PubMed Central
Fig. 2 Ori inhibits NLRP3 inflammasome assembly by blocking NEK7–NLRP3 interaction. a Western blot analysis of cross-linked ASC in the Nonidet P-40–insoluble pellet of BMDMs stimulated with nigericin in the presence or absence of Ori. b An endogenous immunoprecipitation (IP) with NEK7 antibody or isotype antibody was performed in LPS-primed BMDMs stimulated with nigericin in the presence or absence of Ori. c An endogenous IP with ASC antibody or isotype antibody was performed in LPS-primed BMDMs stimulated with nigericin in the presence or absence of Ori. d IP and western blot analysis of NEK7–NLRP3 interaction in HEK-293T cells. e IP and western blot analysis of the interaction between purified NEK7 and NLRP3. f IP and western blot analysis of NLRP3 oligomerization in HEK-293T cells. g IP and western blot analysis of ASC-NLRP3 interaction in HEK-293T cells. Data are representative of three independent experiments
Fig. 2 Ori inhibits NLRP3 inflammasome assembly by blocking NEK7–NLRP3 interaction. a Western blot analysis of cross-linked ASC in the Nonidet P-40–insoluble pellet of BMDMs stimulated with nigericin in the presence or absence of Ori. b An endogenous immunoprecipitation (IP) with NEK7 antibody or isotype antibody was performed in LPS-primed BMDMs stimulated with nigericin in the presence or absence of Ori. c An endogenous IP with ASC antibody or isotype antibody was performed in LPS-primed BMDMs stimulated with nigericin in the presence or absence of Ori. d IP and western blot analysis of NEK7–NLRP3 interaction in HEK-293T cells. e IP and western blot analysis of the interaction between purified NEK7 and NLRP3. f IP and western blot analysis of NLRP3 oligomerization in HEK-293T cells. g IP and western blot analysis of ASC-NLRP3 interaction in HEK-293T cells. Data are representative of three independent experimentsCC BY · PubMed Central
Fig. 3 Ori binds to NLRP3 NACHT domain. a Cell lysates of LPS-primed BMDMs were incubated with bio-Ori for 2 h, which were then pulled down using streptavidin beads. The total proteins (input), bound proteins (PD) and remained proteins (After PD) were immunoblotted as indicated. b Cell lysates of LPS-primed BMDMs were incubated with bio-Ori (1 μM) and different concentrations of free Ori (20 μM, 40 μM), which were then pulled down using streptavidin beads. c Cell lysates of LPS-primed BMDMs incubated with bio-Ori or biotin and detected by Strep-HRP. d HEK-293T cell lysates overexpressing Flag-NLRP3 were incubated with bio-Ori or biotin and detected by Strep-HRP. e Purified human GFP-NLRP3 protein was incubated with indicated doses of bio-Ori (0.1 μM, 1 μM) and then pulled down using streptavidin beads. f MST assay for the affinity between Ori and purified GFP-NLRP3 protein. g–h Flag-tagged NLRP3, AIM2, NLRC4 or NLRP1 (g), NLRP3-LRR, NLPR3-NACHT or NLRP3-PYD (h) was expressed in HEK-293T cells. The HEK-293T cell lysates were incubated with bio-Ori (1 μM) and then were pulled down using streptavidin beads. Data are representative of two or three independent experiments
Fig. 3 Ori binds to NLRP3 NACHT domain. a Cell lysates of LPS-primed BMDMs were incubated with bio-Ori for 2 h, which were then pulled down using streptavidin beads. The total proteins (input), bound proteins (PD) and remained proteins (After PD) were immunoblotted as indicated. b Cell lysates of LPS-primed BMDMs were incubated with bio-Ori (1 μM) and different concentrations of free Ori (20 μM, 40 μM), which were then pulled down using streptavidin beads. c Cell lysates of LPS-primed BMDMs incubated with bio-Ori or biotin and detected by Strep-HRP. d HEK-293T cell lysates overexpressing Flag-NLRP3 were incubated with bio-Ori or biotin and detected by Strep-HRP. e Purified human GFP-NLRP3 protein was incubated with indicated doses of bio-Ori (0.1 μM, 1 μM) and then pulled down using streptavidin beads. f MST assay for the affinity between Ori and purified GFP-NLRP3 protein. g–h Flag-tagged NLRP3, AIM2, NLRC4 or NLRP1 (g), NLRP3-LRR, NLPR3-NACHT or NLRP3-PYD (h) was expressed in HEK-293T cells. The HEK-293T cell lysates were incubated with bio-Ori (1 μM) and then were pulled down using streptavidin beads. Data are representative of two or three independent experimentsCC BY · PubMed Central
Fig. 4 Ori covalently binds to the cysteine 279 on NLRP3. a ELISA of IL-1β in SN from LPS-primed BMDMs treated with different doses of Ori for 15 min and washed three times, then stimulated with nigericin. b Cell lysates of LPS-primed BMDMs were incubated with different concentrations of free Ori for 2 h before or after incubated with bio-Ori (1 μM) for 2 h, and then pulled down using streptavidin beads. c HEK-293T cells were transfected with Flag-tagged WT or indicated mutant NLRP3 constructs. The cell lysates were incubated with bio-Ori (1 μM) and then were pulled down using streptavidin beads. d IP and western blot analysis of the interaction between NEK7 and WT or mutant NLRP3 in HEK-293T cells. e, f Western blot analysis (e) of cleaved IL-1β and activated caspase-1 or ELISA of IL-1β (f) in SN from LPS-primed Nlrp3-/- BMDM reconstituted with WT or mutant NLRP3 (C275A) that were pretreated with Ori (2 μM) for 0.5 h and then stimulated with nigericin. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (a, f) or are representative of three independent experiments (b–e). Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001
Fig. 4 Ori covalently binds to the cysteine 279 on NLRP3. a ELISA of IL-1β in SN from LPS-primed BMDMs treated with different doses of Ori for 15 min and washed three times, then stimulated with nigericin. b Cell lysates of LPS-primed BMDMs were incubated with different concentrations of free Ori for 2 h before or after incubated with bio-Ori (1 μM) for 2 h, and then pulled down using streptavidin beads. c HEK-293T cells were transfected with Flag-tagged WT or indicated mutant NLRP3 constructs. The cell lysates were incubated with bio-Ori (1 μM) and then were pulled down using streptavidin beads. d IP and western blot analysis of the interaction between NEK7 and WT or mutant NLRP3 in HEK-293T cells. e, f Western blot analysis (e) of cleaved IL-1β and activated caspase-1 or ELISA of IL-1β (f) in SN from LPS-primed Nlrp3-/- BMDM reconstituted with WT or mutant NLRP3 (C275A) that were pretreated with Ori (2 μM) for 0.5 h and then stimulated with nigericin. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (a, f) or are representative of three independent experiments (b–e). Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 5 Ori binds to NLRP3 via its active carbon–carbon double-bond. a Structure of Ori without carbon–carbon double-bond (R-Ori). b Cell lysates of LPS-primed BMDMs were incubated with bio-Ori (1 μM) or indicated doses of bio-R-Ori for 2 h, and then pulled down using streptavidin beads. c, d Western blot analysis (c) of cleaved IL-1β and activated caspase-1 or ELISA of IL-1β (d) in SN from LPS-primed BMDMs pretreated with Ori (2 μM) or R-Ori (2 μM) for 0.5 h and then stimulated with nigericin. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (d) or are representative of three independent experiments (b, c). Statistical differences were calculated by unpaired Student’s t-test: ***P < 0.001
Fig. 5 Ori binds to NLRP3 via its active carbon–carbon double-bond. a Structure of Ori without carbon–carbon double-bond (R-Ori). b Cell lysates of LPS-primed BMDMs were incubated with bio-Ori (1 μM) or indicated doses of bio-R-Ori for 2 h, and then pulled down using streptavidin beads. c, d Western blot analysis (c) of cleaved IL-1β and activated caspase-1 or ELISA of IL-1β (d) in SN from LPS-primed BMDMs pretreated with Ori (2 μM) or R-Ori (2 μM) for 0.5 h and then stimulated with nigericin. Data are expressed as mean and s.e.m (n = 6) from three independent experiments (d) or are representative of three independent experiments (b, c). Statistical differences were calculated by unpaired Student’s t-test: ***P < 0.001CC BY · PubMed Central
Fig. 6 Ori suppresses NLRP3-dependent peritonitis and gouty arthritis. a, b ELISA of IL-1β in the serum (a) or peritoneal cavity (b) from WT or Nlrp3-/- mice intraperitoneally injected with MSU crystals (1 mg/mouse) in the presence or absence of Ori (20 mg/kg). Data expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. c FACS analysis of neutrophil numbers in the peritoneal cavity from WT or Nlrp3-/- mice intraperitoneally injected with MSU crystals (1 mg/mouse) in the presence or absence of Ori (20 mg/kg). Data are expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. d, e The joint swelling in different time points (d) or ELISA of IL-1β (e) in joint culture from WT or Nlrp3-/- mice, which have been intraarticularly injected with MSU with or without Ori (20 mg/kg). Data are expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001
Fig. 6 Ori suppresses NLRP3-dependent peritonitis and gouty arthritis. a, b ELISA of IL-1β in the serum (a) or peritoneal cavity (b) from WT or Nlrp3-/- mice intraperitoneally injected with MSU crystals (1 mg/mouse) in the presence or absence of Ori (20 mg/kg). Data expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. c FACS analysis of neutrophil numbers in the peritoneal cavity from WT or Nlrp3-/- mice intraperitoneally injected with MSU crystals (1 mg/mouse) in the presence or absence of Ori (20 mg/kg). Data are expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. d, e The joint swelling in different time points (d) or ELISA of IL-1β (e) in joint culture from WT or Nlrp3-/- mice, which have been intraarticularly injected with MSU with or without Ori (20 mg/kg). Data are expressed as mean and s.e.m (n = 6) and are representative of two independent experiments. Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 7 Treatment of metabolic disorders in HFD-induced diabetic mice with Ori. a, b Food intake and body weights of 16-week HFD-fed WT or Nlrp3-/- mice after 6-week vehicle or Ori treatment. n = 26 per group. c, d Fasting (c) or fed (d) blood glucose levels of 16-week HFD-fed WT or Nlrp3-/- mice treated with vehicle or Ori for 6 weeks. n = 6 per group. e–h GTT (e, g) or ITT (f, h) of 16-week HFD-fed WT or Nlrp3-/- mice treated with vehicle or Ori for 6 weeks. Data are expressed as mean and s.e.m and are representative of two independent experiments. Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001, NS, not significant
Fig. 7 Treatment of metabolic disorders in HFD-induced diabetic mice with Ori. a, b Food intake and body weights of 16-week HFD-fed WT or Nlrp3-/- mice after 6-week vehicle or Ori treatment. n = 26 per group. c, d Fasting (c) or fed (d) blood glucose levels of 16-week HFD-fed WT or Nlrp3-/- mice treated with vehicle or Ori for 6 weeks. n = 6 per group. e–h GTT (e, g) or ITT (f, h) of 16-week HFD-fed WT or Nlrp3-/- mice treated with vehicle or Ori for 6 weeks. Data are expressed as mean and s.e.m and are representative of two independent experiments. Statistical differences were calculated by unpaired Student’s t-test: **P < 0.01, ***P < 0.001, NS, not significantCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 827

Metadata

Authors
He, H., Jiang, H., Chen, Y., Ye, J., Wang, A., Wang, C., Liu, Q., Liang, G., Deng, X., Jiang, W., & Zhou, R.
Affiliations
  • University of Science and Technology of China (CN)
  • Xiamen University (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Deng, Xianming
  • Jiang, Wei
  • Zhou, Rongbin
Venue
Nature Communications
Published
2018-06-29
Volume
9
Issue
1
Pages
2550-2550
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2810072585
Cited by
827
References
61
Citations by year
2026: 115 · 2025: 126 · 2024: 139 · 2023: 128 · 2022: 99 · 2021: 98 · 2020: 87 · 2019: 27 · 2018: 7
FWCI
19.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2014CB910800)
  • Chinese Academy of Sciences (XDPB03)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
oridonin, NLRP3 inflammasome, covalent inhibition, Rabdosia rubescens, anti-inflammatory activity, NEK7, NACHT domain, peritonitis, gout, type 2 diabetes, chronic inflammation, traditional Chinese medicine
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, NIMA-Related Kinases, Animals, Anti-Inflammatory Agents, Blood Glucose, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Humans, Inflammation, Mice, Inbred C57BL, Peritonitis, Plant Extracts, Protein Binding, Arthritis, Gouty, Signal Transduction, Mice, Knockout, Isodon, Diterpenes, Kaurane, Mice, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. https://app.cochat.ai/papers/10.1038/s41467-018-04947-6
The paper
He, H., Jiang, H., Chen, Y., Ye, J., Wang, A., Wang, C., Liu, Q., Liang, G., Deng, X., Jiang, W., & Zhou, R. (2018). Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nature Communications. https://doi.org/10.1038/s41467-018-04947-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.